UK markets closed

Shield Therapeutics plc (STX.L)

LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
2.0500-0.0250 (-1.20%)
At close: 04:04PM BST
Show:
Income statement
Balance sheet
Annual

Cash flow

Currency in USD. All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-33,293
-33,293
-49,789
-26,558
-3,584
Depreciation & amortisation
1,071
1,071
2,662
2,979
3,686
Stock-based compensation
875
875
912
1,339
1,051
Change in working capital
-7,024
-7,024
3,925
-2,420
-3,573
Inventory
-1,446
-1,446
215
-345.5071
-587.3775
Other working capital
-40,074
-40,074
-24,876
-27,433
-1,939
Other non-cash items
501
501
374
39.1395
-365.2371
Net cash provided by operating activities
-37,126
-37,126
-22,591
-24,647
-1,908
Cash flows from investing activities
Investments in property, plant and equipment
-2,948
-2,948
-2,285
-2,786
-31.345
Net cash used for investing activities
-2,430
-2,430
-2,249
-2,768
-27.2565
Net change in cash
10,100
10,100
-11,812
9,986
-1,999
Cash at beginning of period
3,402
3,402
16,345
3,968
5,643
Cash at end of period
13,948
13,948
3,402
16,354
4,007
Free cash flow
Operating cash flow
-37,126
-37,126
-22,591
-24,647
-1,908
Capital expenditure
-2,948
-2,948
-2,285
-2,786
-31.345
Free cash flow
-40,074
-40,074
-24,876
-27,433
-1,939